Gainers
- Kiromic BioPharma KRBP shares increased by 5.26% to $3.0 during Friday's after-market session. The market value of their outstanding shares is at $46.3 million.
- Accelerate Diagnostics AXDX shares moved upwards by 4.03% to $6.44. The company's market cap stands at $434.2 million.
- InVivo Therapeutics Hldg NVIV stock rose 3.49% to $0.59. The company's market cap stands at $20.2 million.
- Sage Therapeutics SAGE stock increased by 3.01% to $46.5. This security traded at a volume of 108.2K shares come close, making up 20.44% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.7 billion. The company's, Q3 earnings came out 3 days ago.
- OraSure Technologies OSUR stock rose 2.89% to $9.95. At the close, OraSure Technologies's trading volume reached 175.2K shares. This is 23.03% of its average volume over the last 100 days. The market value of their outstanding shares is at $716.4 million. The company's, Q3 earnings came out 2 days ago.
- Surgalign Holdings SRGA shares moved upwards by 2.8% to $1.1. Today's trading volume for this security ended up closing at 64.5K shares, which is 1.65 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $153.3 million.
Losers
- Alimera Sciences ALIM stock declined by 7.37% to $5.28 during Friday's after-market session. The market value of their outstanding shares is at $36.5 million.
- Exicure XCUR shares fell 4.51% to $1.06. The market value of their outstanding shares is at $93.3 million.
- NanoVibronix NAOV shares fell 3.58% to $1.62. This security traded at a volume of 95.0K shares come close, making up 0.71% of its average volume over the last 100 days. The company's market cap stands at $39.0 million.
- Axcella Health AXLA shares decreased by 3.5% to $3.04. The market value of their outstanding shares is at $116.0 million.
- Assertio Holdings ASRT shares declined by 3.29% to $1.47. This security traded at a volume of 530.1K shares come close, making up 89.73% of its average volume over the last 100 days. The market value of their outstanding shares is at $65.4 million. The company's, Q3 earnings came out yesterday.
- Phio Pharmaceuticals PHIO stock declined by 2.91% to $1.67. The company's market cap stands at $22.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in